China's WuXi Biologics Snaps up Second European Pharma Plant

China's pharmaceutical major, WuXi Biologics, has purchased another manufacturing plant in Germany from Bayer, stating that it will support its global expansion network for supplying…

China | Pharmaceutical & Biotech | Industrial Info | China Renewable Projects | covid

Industrial Info

Wed Dec 30 2020

China Expects to Add 28 GW of Solar Power in 2017

In 2016, China's installed capacity of solar photovoltaic power increased by 34.54 gigawatts (GW), which was much more than the original expectation of between…

China Renewable Projects | China Solar Power | China Solar Projects | China Renewables

Industrial Info

Fri Mar 03 2017

China's WuXi Biologics Snaps up Second European Pharma Plant

China's pharmaceutical major, WuXi Biologics, has purchased another manufacturing plant in Germany from Bayer, stating that it will support its global expansion network for supplying COVID-19 vaccines and other biologics. Wuxi agreed to pay 150 million euro ($183 million) for Bayer's drug product manufacturing plant in Wuppertal. This is WuXi's second European plant and the second one it has purchased »

China Expects to Add 28 GW of Solar Power in 2017

In 2016, China's installed capacity of solar photovoltaic power increased by 34.54 gigawatts (GW), which was much more than the original expectation of between 20 and 25 GW. At the end of the year, China's accumulative installed capacity of photovoltaic power was 77.42 GW. The accumulative installed capacity of centralized photovoltaic power stations reached 67.1 GW, and »